octopamine
Megjelenés
| Clinical data | |
|---|---|
| Trade names | Epirenor, Norden, Norfen |
| Other names | OCT, Norsympathol, Norsynephrine, para-Octopamine, beta-Hydroxytyramine, 4,β-dihydroxyphenethylamine, para-hydroxy-phenyl-ethanolamine, α-(Aminomethyl)-4 hydroxybenzenemethanol, 1-(p-Hydroxyphenyl)-2-aminoethanol |
| Routes of administration | Oral |
| ATC code | |
| Physiological data | |
| Source tissues | Invertebrate nervous systems; trace amine in vertebrates |
| Target tissues | System-wide in invertebrates |
| Receptors | TAAR1 (mammals) OctαR, OctβR, TyrR (invertebrates), Oct-TyrR |
| Agonists | Formamidines (amitraz (AMZ) and chlordimeform (CDM)) |
| Antagonists | Epinastine |
| Precursor | Tyramine |
| Biosynthesis | Tyramine β-hydroxylase; dopamine β-hydroxylase |
| Metabolism | p-Hydroxymandelic acid; |
| Legal status | |
| Legal status |
|
| Pharmacokinetic data | |
| Bioavailability | 99.42% |
| Metabolism | p-Hydroxymandelic acid; |
| Elimination half-life | 15 minutes in insects. Between 76 and 175 minutes in humans |
| Excretion | Up to 93% of ingested octopamine is eliminated via the urinary route within 24 hours |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEBI | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C8H11NO2 |
| Molar mass | 153.181 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Főnév
octopamine (tsz. octopamines)
- octopamine - Szótár.net (en-hu)
- octopamine - Sztaki (en-hu)
- octopamine - Merriam–Webster
- octopamine - Cambridge
- octopamine - WordNet
- octopamine - Яндекс (en-ru)
- octopamine - Google (en-hu)
- octopamine - Wikidata
- octopamine - Wikipédia (angol)